Business
“Reality check”: In early data, AstraZeneca vaccine offers minimal protection against South African variant – Sydney Morning Herald
Australian health authorities have backed AstraZeneca’s vaccine despite South Africa’s decision to pause roll-out of the jab, after early clinical data showed it…
It remains unclear if the vaccine will still protect against serious illness and death; scientists who were part of the South African trial are hopeful it will.
The University of Oxford, which co-developed the vaccine, said it was working on a booster jab to provide protection against the variant, if necessary.
CSL, which is contracted by the government and AstraZeneca to produce 50 million doses of the vaccine at its Broadmeadows plant, did not comment directly on whether it could modify the jab…
-
General17 hours agoUS CDC boss Susan Monarez refuses to quit, defying Trump’s White House
-
General14 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
General22 hours agoPolice offer ‘surrender plan’ to Dezi Freeman as fugitive avoids capture for another day
-
General20 hours agoGeelong Cats AFL star Bailey Smith details mental health battle during All-Australian speech